Dr. Reddy's Laboratories
159 hedge funds and large institutions have $1.32B invested in Dr. Reddy's Laboratories in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 51 reducing their positions, and 28 closing their positions.
18% more capital invested
Capital invested by funds: $1.12B → $1.32B (+$204M)
2% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 51
2.25% less ownership
Funds ownership: 76.17% → 73.91% (-2.3%)
6% less funds holding
Funds holding: 169 → 159 (-10)
15% less call options, than puts
Call options by funds: $268K | Put options by funds: $315K
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$26.1M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$10.6M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
+$10.4M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$7.83M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$6.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Segantii Capital Management
Hong Kong
|
-$12.3M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6.75M |
| 3 |
SGA
Sector Gamma AS
Oslo,
Norway
|
-$6.31M |
| 4 |
VAM
Visium Asset Management
New York
|
-$5.84M |
| 5 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$5.22M |
RDY Hedge Fund Activity: Q3 2014 in Review
159 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2014, worth a combined $1.32B — up 18% from $1.12B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of RDY and 21 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 52 added.
The largest buyer was Arrowstreet Capital, adding an estimated $26.1M. The largest seller was Segantii Capital Management, exiting entirely with an estimated $12.3M sold.
- 159 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2014, down from 169 in Q2 2014.
- Funds reported $1.32B of Dr. Reddy's Laboratories stock for Q3 2014, up 18% quarter-over-quarter.
- 21 funds opened new Dr. Reddy's Laboratories positions in Q3 2014 and 28 closed out, a net change of -7 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2014 was Arrowstreet Capital, an estimated $26.1M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2014 was Segantii Capital Management, an estimated $12.3M sold.
Based on aggregated 13F filings for Q3 2014.